Secondaries Announced 3.21.2017

IPO BOUTIQUE CLIENTS and IPO BOUTIQUE SECONDARY ALERTS CLIENTS received ALL this information to their inbox on a REAL TIME basis.

If having real-time alerts for secondary offerings would be an advantage to you, inquire about a subscription today!

Our Buy, Neutral or Avoid ratings of the Secondaries below are intended as a recommendation for those who buy Secondaries on a regular basis. For example, this is not to be interpreted as a Buy recommendation in the traditional sense of adding to your stock portfolio; this is a short term (usually one day or opening trade) time period. Spot secondaries or block trades due to the very short duration of announcement to trading, may take longer to “work”, and should be judged accordingly. (the key is the pricing for spots and or blocks…even more so than scheduled secondaries)
Company: Regenxbio Inc.
Symbol: RGNX
Price: Last Trade $22.10
Trade Date: Subscription Needed
Shares: 3.4 million
Re-Offer Range: Subscription Needed
Underwriter(s) Morgan Stanley BofA Merrill Lynch, Piper Jaffray
Co-Manager: Chardan Capital Markets
Rating = Subscription Needed

Company: Vital Therapies, Inc.
Symbol: VTL
Price: Last Trade $4.25
Re-offer: Subscription Needed
Trade Date: Subscription Needed
Shares: 7.3 million
Underwriter(s) Raymond James
Co-Manager: National Securities
Rating = Subscription Needed

Company: Easterly Government Properties, Inc.
Symbol: DEA
Price: Last Trade $19.67
Trade Date: Subscription Needed
Shares: 4.3 million
Re-Offer Range: Subscription Needed
Underwriter(s) Jefferies, Citigroup, Raymond James, RBC Capital Markets
Rating = Subscription Needed

Company: Adaptimmune Therapeutics plc
Symbol: ADAP
Price: Last Trade $4.29
Re-offer: Subscription Needed
Trade Date: Subscription Needed
Shares: Subscription Needed
Underwriter(s) Citigroup, Cowen and Company, Leerink Partners
Rating = Subscription Needed